World Hepatitis Day

Today, JIAS marks World Hepatitis Day, reflecting particularly on issues related to the burden of hepatitis C among people living with HIV. Observed on 28 July, this international day aims at raising global awareness of hepatitis and encourage prevention, diagnosis and treatment. On this occasion, we highlight two articles, which advocate for further addressing the burden of HIV-HCV co-infection in Latin America and the Caribbean region, and among people who inject drugs (PWID).
In his viewpoint article, JIAS editorial board member Luis Soto-Ramirez, presents an overview of the current prevalence of hepatitis in Latin America and the Caribbean region, and of public-health efforts to curb the epidemic. Few comprehensive estimates are available for this region, and, not coincidentally, there is a lack of leadership in the region on recognizing the seriousness of the issue, and making the necessary efforts to tackle it. Dr. Soto-Ramirez’s overview is a much-needed call to action:
Hepatitis C virus (HCV) infection is a major comorbidity among PWID living with HIV, and a large proportion of the global HCV burden and new cases of infection occur among PWID. In their commentary, Jason Grebely and colleagues clearly lay out the necessary steps to achieve the World Health Organization targets of reducing new HCV infections by 80%, and deaths from HCV by 65% by 2030. The targets are ambitious but, the authors contend, achievable in many countries – provided that all stakeholders (policy makers, the pharmaceutical industry, healthcare providers, etc.) all work together towards this shared goal. Be sure to read the article in full here:
We encourage you to read these articles in their entirety and to share them widely as we continue to raise awareness on this World Hepatitis Day.

Journal of the International AIDS Society | eISSN 1758-2652 | Editors-in-Chief: Susan Kippax and Kenneth Mayer

*2016 Journal Citation Reports® Science Edition - a Clarivate Analytics product.

Disclaimer: The Journal of the International AIDS Society is an official journal of and is published by the International AIDS Society. The costs of the Journal of the International AIDS Society are secured by the International AIDS Society. This support does not in any way affect the editorial independency of the Journal of the International AIDS Society. Material published in the journal is entirely independent of the opinion of external sponsors and the society.